Delivery Order SPE2DB22D3102-SPE2DB24FL2HE

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,546.20 firm-fixed-price contract is for the supply of Tobradex Eye Ointment, a prescription ophthalmic medication. The contract has a completion date of May 14, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Tobradex Eye Ointment. The one-year contract has a firm fixed price of $1,247.58 and runs through January 30, 2024. This order is not part of a set-aside program. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tobradex Eye Ointment 3.5 gm, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,022.74 and a completion date of May 9, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobradex Eye Ointment 3.5GM. The contract has a firm fixed price, a ceiling value of $1,108.89, and a period of performance through March 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.01 Firm Fixed Price Delivery Order is for the supply of Tobradex Eye Ointment 3.5GM, a pharmaceutical product, with a performance period ending in April 2025. The award is not associated with a set-aside program and appears to be part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Tobradex eye ointment. The $3,430.52 firm-fixed-price contract has a performance period ending on March 30, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX eye ointment. The order is valued at $6,353.15 and has a firm fixed price. The contract has an ultimate completion date of August 27, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.47 Firm Fixed Price Delivery Order contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,728.47, is for the delivery of Tobrex 0.3% eye ointment, 3.5g. The award has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division for the delivery of TOBRADEX EYE OINTMENT 3.5GM. The $2,095.52 firm fixed-price delivery order has an ultimate completion date of April 22, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 31, 2025, which serves as...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL2HE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Tobradex Eye Ointment 3.5 GM. The $3,244.52 firm-fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical ophthalmic medication supplies to support military treatment facilities and other government healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen. The contract does not have a small business set-aside designation.

Generated 10/31/24, 9:18 AM